Overall, our findings show how removal of maternal pomgnt2 mRNA in oocytes is necessary to unmask developmental phenotypes that recapitulate the core dystroglycanopathy phenotypes. Here, POMGNT2 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.